Author: Business Wire

Horizon Pharma plc Announces Presentation of Results of 48 Week Off-Therapy Follow-Up to the Phase 2 Trial of Teprotumumab at 2018 American Academy of Ophthalmology (AAO) Annual Meeting

DUBLIN–(BUSINESS WIRE)–Horizon Pharma plc (NASDAQ:HZNP) announced that more detailed results from the 48 week off-therapy follow-up to the Phase 2 clinical trial of teprotumumab for people living with moderate-to-severe active thyroid eye disease (TE…

CHA Hollywood Presbyterian Medical Center Announces Rohit Varma, MD, MPH, World Renowned Eye Care Specialist, as Founding Director of the Southern California Eyecare and Vision Research Institute

LOS ANGELES–(BUSINESS WIRE)–CHA Hollywood Presbyterian Medical Center (CHA HPMC), a subsidiary of CHA Health Systems, a global leader in bio-technology and healthcare, and Dr. Rohit Varma have partnered to form the new Southern California Eyecare and…